Sponsored Content

A Different Kind of CRO

Altasciences is a forward-thinking CRO for biopharma companies that recognize that time saved is opportunity gained, and opportunity gained is value realized.

Company Logo

Released By Altasciences

Altasciences is a forward-thinking CRO for biopharmaceutical companies that recognize that time saved is opportunity gained, and opportunity gained is value realized. We are a different kind of CRO — always available and always looking ahead … Moving in Unison to deliver big impact with a personal touch.

Altasciences is a mid-size, early phase contract research organization with a unique company focus on supporting drug development from lead candidate selection to proof of concept. With over 25 years of industry experience, we provide preclinical and clinical solutions to an international customer base of biopharmaceutical companies. Altasciences’ full-service offering includes program management, preclinical safety testing, clinical pharmacology services, medical writing, biostatistics, data management, and bioanalysis services; all tailored to your specific research requirements.













We have an AAALAC-accredited, purpose-built preclinical facility with over 140 animal rooms, including European housing, which is fully compliant with FDA and OECD GLP requirements. Altasciences’ solution offering includes IND/NDA-enabling toxicology, safety pharmacology, and laboratory services. Our team of scientists and technicians has been conducting toxicology studies for decades, and is committed to working as an extension of our clients, moving in unison, going above and beyond to meet your critical milestones. Altasciences offers a full range of in vivo GLP and non-GLP preclinical evaluation studies in both rodent and non-rodent species.
 
Altasciences’ clinical experts are at the ready. Each year, we successfully complete hundreds of clinical trials to proof of concept, in a wide range of therapeutic areas. We have clinical locations in the U.S. and Canada and a database of 365,000 participants (healthy normal and patient populations). Regardless of participant type or length of stay, our recruitment and retention rates are excellent, with 95% on-time cohorts, year after year. To support our clinical pharmacology trials from First-In-Human to Phase II, we offer research services including medical writing, biostatistics, data management, and project management.
 
We have state-of-the-art, purpose-built bioanalytical laboratories at our locations in the U.S. and Canada, with designated containment Level 2 areas for work with Risk Group 2 pathogens. Staffed by highly-skilled analysts, and shifts running 24/7 (as needed), we can process over 60,000 study samples per month. Responsive and flexible, our team of over 100 bioanalytical subject matter experts is there for you, throughout all stages of your drug development pathway. Following clear processes, in accordance with GLP and current FDA/EMA guidelines, and supported by our unique array of platforms and large list of validated assays, our team ensures the most effective methods for your individual programs.













Altasciences offers a simplified pathway for full drug development programs. Our outsourcing platform enables you to work with a single, integrated partner from lead candidate selection to proof of concept. Our Program Managers are the single point of contact for a comprehensive, full-service package designed to minimize hand-offs, resulting in shorter timelines.
 
Our scientific team will work closely with you to design the most efficient preclinical or clinical studies and support your bioanalytical needs while meeting all regulatory requirements. Our goal is to make the process seamless for you as you move from one milestone to the next.
 
Speak to one of our experts today.


contact@altasciences.com | altasciences.com

Request more information from Altasciences

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters